Platelet receptor polymorphisms do not influence Staphylococcus aureus-platelet interactions or infective endocarditis

Microbes and Infection

Volumn 13, Issue 3, 2011, Pages 216-225

  Daga, Shruti ^a,b   Shepherd, James G ^a,b   Callaghan, J Garreth S ^a,b   Hung, Rachel K Y ^a,b   Dawson, Dana K ^b   Padfield, Gareth J ^b   Hey, Shi Y ^a,b   Cartwright, Robyn A ^a   Newby, David E ^b   Fitzgerald, J Ross ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Endocarditis; Genetic polymorphisms; Platelet aggregation

Indexed keywords

FC RECEPTOR IIA; FIBRINOGEN RECEPTOR;

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ARTICLE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MALE; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADULT; AGED; BLOOD PLATELETS; ENDOCARDITIS; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INTEGRIN BETA3; MALE; MIDDLE AGED; PLATELET ACTIVATION; POLYMORPHISM, GENETIC; RECEPTORS, IGG; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STATISTICS, NONPARAMETRIC;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 78951480206     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.10.016     Document Type: Article

References (43)

1. Horstkotte D., Follath F., Gutschik E., Lengyel M., Oto A., Pavie A., Soler-Soler J., Thiene G., von Graevenitz A., Priori S.G., Garcia M.A., Blanc J.J., Budaj A., Cowie M., Dean V., Deckers J., Fernandez Burgos E., Lekakis J., Lindahl B., Mazzotta G., Morais J., Oto A., Smiseth O.A., Lekakis J., Vahanian A., Delahaye F., Parkhomenko A., Filipatos G., Aldershvile J., Vardas P. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur. Heart J. 2004, 25:267-276.
2. Murdoch D.R., Corey G.R., Hoen B., Miro J.M., Fowler V.G., Bayer A.S., Karchmer A.W., Olaison L., Pappas P.A., Moreillon P., Chambers S.T., Chu V.H., Falco V., Holland D.J., Jones P., Klein J.L., Raymond N.J., Read K.M., Tripodi M.F., Utili R., Wang A., Woods C.W., Cabell C.H. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch. Intern. Med. 2009, 169:463-473.
3. Watanakunakorn C., Burkert T. Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes. Medicine (Baltimore) 1993, 72:90-102.
4. Cabell C.H., Jollis J.G., Peterson G.E., Corey G.R., Anderson D.J., Sexton D.J., Woods C.W., Reller L.B., Ryan T., Fowler V.G. Changing patient characteristics and the effect on mortality in endocarditis. Arch. Intern. Med. 2002, 162:90-94.
5. Durack D.T. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J. Pathol. 1975, 115:81-89.
6. Ferguson D.J., McColm A.A., Ryan D.M., Acred P. A morphological study of experimental staphylococcal endocarditis and aortitis. II. Inter-relationship of bacteria, vegetation and cardiovasculature in established infections. Br. J. Exp. Pathol. 1986, 67:679-686.
7. Rouzet F., Dominguez Hernandez M., Hervatin F., Sarda-Mantel L., Lefort A., Duval X., Louedec L., Fantin B., Le Guludec D., Michel J.B. Technetium 99m-labeled annexin V scintigraphy of platelet activation in vegetations of experimental endocarditis. Circulation 2008, 117:781-789.
8. Cabell C.H., Pond K.K., Peterson G.E., Durack D.T., Corey G.R., Anderson D.J., Ryan T., Lukes A.S., Sexton D.J. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am. Heart J. 2001, 142:75-80.
9. De Castro S., Magni G., Beni S., Cartoni D., Fiorelli M., Venditti M., Schwartz S.L., Fedele F., Pandian N.G. Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am. J. Cardiol. 1997, 80:1030-1034.
10. Di Salvo G., Habib G., Pergola V., Avierinos J.F., Philip E., Casalta J.P., Vailloud J.M., Derumeaux G., Gouvernet J., Ambrosi P., Lambert M., Ferracci A., Raoult D., Luccioni R. Echocardiography predicts embolic events in infective endocarditis. J. Am. Coll. Cardiol. 2001, 37:1069-1076.
11. Fitzgerald J.R., Foster T.J., Cox D. The interaction of bacterial pathogens with platelets. Nat. Rev. Microbiol. 2006, 4:445-457.
12. Phillips D.R., Charo I.F., Parise L.V., Fitzgerald L.A. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988, 71:831-843.
13. Newman P.J., Derbes R.S., Aster R.H. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J. Clin. Invest. 1989, 83:1778-1781.
14. Vijayan K.V., Bray P.F. Molecular mechanisms of prothrombotic risk due to genetic variations in platelet genes: enhanced outside-in signaling through the Pro33 variant of integrin beta3. Exp. Biol. Med. (Maywood) 2006, 231:505-513.
15. Feng D., Lindpaintner K., Larson M.G., Rao V.S., O'Donnell C.J., Lipinska I., Schmitz C., Sutherland P.A., Silbershatz H., D'Agostino R.B., Muller J.E., Myers R.H., Levy D., Tofler G.H. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1142-1147.
16. Meisel C., Lopez J.A., Stangl K. Role of platelet glycoprotein polymorphisms in cardiovascular diseases. Naunyn Schmiedebergs Arch. Pharmacol. 2004, 369:38-54.
17. Michelson A.D., Furman M.I., Goldschmidt-Clermont P., Mascelli M.A., Hendrix C., Coleman L., Hamlington J., Barnard M.R., Kickler T., Christie D.J., Kundu S., Bray P.F. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 2000, 101:1013-1018.
18. Chen J., Dong J.F., Sun C., Bergeron A., McBride L., Pillai M., Barnard M.R., Salmon J., Michelson A.D., Bray P.F. Platelet FcgammaRIIA His131Arg polymorphism and platelet function: antibodies to platelet-bound fibrinogen induce platelet activation. J. Thromb. Haemost. 2003, 1:355-362.
19. Lehrnbecher T., Foster C.B., Zhu S., Leitman S.F., Goldin L.R., Huppi K., Chanock S.J. Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood 1999, 94:4220-4232.
20. van der Pol W., van de Winkel J.G. IgG receptor polymorphisms: risk factors for disease. Immunogenetics 1998, 48:222-232.
21. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler V.G., Ryan T., Bashore T., Corey G.R. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis. 2000, 30:633-638.
22. Bashore T.M., Cabell C., Fowler V. Update on infective endocarditis. Curr. Probl. Cardiol. 2006, 31:274-352.
23. O'Brien L., Kerrigan S.W., Kaw G., Hogan M., Penades J., Litt D., Fitzgerald D.J., Foster T.J., Cox D. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol. Microbiol. 2002, 44:1033-1044.
24. Yeaman M.R., Sullam P.M., Dazin P.F., Norman D.C., Bayer A.S. Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis. J. Infect. Dis. 1992, 166:65-73.
25. Fitzgerald J.R., Loughman A., Keane F., Brennan M., Knobel M., Higgins J., Visai L., Speziale P., Cox D., Foster T.J. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol. Microbiol. 2006, 59:212-230.
26. Gudmundsdottir I.J., Megson I.L., Kell J.S., Ludlam C.A., Fox K.A., Webb D.J., Newby D.E. Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans. Circulation 2006, 114:1625-1632.
27. Sarma J., Laan C.A., Alam S., Jha A., Fox K.A., Dransfield I. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002, 105:2166-2171.
28. Laule M., Cascorbi I., Stangl V., Bielecke C., Wernecke K.D., Mrozikiewicz P.M., Felix S.B., Roots I., Baumann G., Stangl K. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study. Lancet 1999, 353:708-712.
29. Feng D., Lindpaintner K., Larson M.G., O'Donnell C.J., Lipinska I., Sutherland P.A., Mittleman M., Muller J.E., D'Agostino R.B., Levy D., Tofler G.H. Platelet glycoprotein IIIa Pl(a) polymorphism, fibrinogen, and platelet aggregability: the Framingham heart study. Circulation 2001, 104:140-144.
30. McNicol A., Zhu R., Pesun R., Pampolina C., Jackson E.C., Bowden G.H., Zelinski T. A role for immunoglobulin G in donor-specific Streptococcus sanguis-induced platelet aggregation. Thromb. Haemost. 2006, 95:288-293.
31. Kessler C.M., Nussbaum E., Tuazon C.U. In vitro correlation of platelet aggregation with occurrence of disseminated intravascular coagulation and subacute bacterial endocarditis. J. Lab. Clin. Med. 1987, 109:647-652.
32. Grundmeier M., Hussain M., Becker P., Heilmann C., Peters G., Sinha B. Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function. Infect. Immun. 2004, 72:7155-7163.
33. Loughman A., Fitzgerald J.R., Brennan M.P., Higgins J., Downer R., Cox D., Foster T.J. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol. Microbiol. 2005, 57:804-818.
34. Di Castelnuovo A., de Gaetano G., Donati M.B., Iacoviello L. Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb. Haemost. 2001, 85:626-633.
35. Musher D., Goldsmith E., Dunbar S., Tilney G., Darouiche R., Yu Q., Lopez J.A., Dong J.F. Association of hypercoagulable states and increased platelet adhesion and aggregation with bacterial colonization of intravenous catheters. J. Infect. Dis. 2002, 186:769-773.
36. Karakas M., Hoffmann M.M., Vollmert C., Rothenbacher D., Meisinger C., Winkelmann B., Khuseyinova N., Bohm B.O., Illig T., Marz W., Koenig W. Genetic variation in Fc gamma receptor IIa and risk of coronary heart disease: negative results from two large independent populations. BMC Med. Genet. 2009, 10:46.
37. Heiro M., Helenius H., Hurme S., Savunen T., Metsarinne K., Engblom E., Nikoskelainen J., Kotilainen P. Long-term outcome of infective endocarditis: a study on patients surviving over one year after the initial episode treated in a Finnish teaching hospital during 25 years. BMC Infect. Dis. 2008, 8:49.
38. Fowler V.G., Miro J.M., Hoen B., Cabell C.H., Abrutyn E., Rubinstein E., Corey G.R., Spelman D., Bradley S.F., Barsic B., Pappas P.A., Anstrom K.J., Wray D., Fortes C.Q., Anguera I., Athan E., Jones P., van der Meer J.T., Elliott T.S., Levine D.P., Bayer A.S. Staphylococcus aureus endocarditis: a consequence of medical progress. J. Am. Med. Assoc. 2005, 293:3012-3021.
39. Faraday N., Goldschmidt-Clermont P.J., Bray P.F. Gender differences in platelet GPIIb-IIIa activation. Thromb. Haemost. 1997, 77:748-754.
40. Franchini M. Hemostasis and aging. Crit. Rev. Oncol. Hematol. 2006, 60:144-151.
41. Kroll M.H., Hellums J.D., McIntire L.V., Schafer A.I., Moake J.L. Platelets and shear stress. Blood 1996, 88:1525-1541.
42. Schlievert P.M., Case L.C., Nemeth K.A., Davis C.C., Sun Y., Qin W., Wang F., Brosnahan A.J., Mleziva J.A., Peterson M.L., Jones B.E. Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins. Biochemistry 2007, 46:14349-14358.
43. Yarwood J.M., McCormick J.K., Schlievert P.M. Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus. J. Bacteriol. 2001, 183:1113-1123.